{"transactions":[{"id":4638097,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-08T21:35:03.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":false,"shares":1990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on May 31, 2017 with respect to 123,000 Common Shares of which 25% shall vest on May 31, 2018 and the remaining 75% shall vest monthly thereafter for 36 months."}],"balance_after":81242,"derivative":{"exercise_price":13.62,"expiration_date":"2027-05-31","underlying":"Common Shares","underlying_shares":1990},"source":{"system":"sec-edgar","filing":"0001193125-26-418101","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708172/000119312526418101/ownership.xml","form_type":"4"}},{"id":4638096,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-10-08T21:35:03.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":1990,"price":60.0408,"value":119481.192,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":94784,"source":{"system":"sec-edgar","filing":"0001193125-26-418101","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708172/000119312526418101/ownership.xml","form_type":"4"}},{"id":4638095,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-10-08T21:35:03.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":true,"shares":1990,"price":13.62,"value":27103.8,"ownership":{"direct":true},"balance_after":96774,"source":{"system":"sec-edgar","filing":"0001193125-26-418101","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708172/000119312526418101/ownership.xml","form_type":"4"}},{"id":4626361,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T21:35:13.000Z","date":"2026-09-22","kind":"exercise","planned":true,"acquired":false,"shares":10400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on May 31, 2017 with respect to 123,000 Common Shares of which 25% shall vest on May 31, 2018 and the remaining 75% shall vest monthly thereafter for 36 months."}],"balance_after":83232,"derivative":{"exercise_price":13.62,"expiration_date":"2027-05-31","underlying":"Common Shares","underlying_shares":10400},"source":{"system":"sec-edgar","filing":"0001193125-26-401237","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708172/000119312526401237/ownership.xml","form_type":"4"}},{"id":4626360,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-09-24T21:35:13.000Z","date":"2026-09-22","kind":"sale","planned":true,"acquired":false,"shares":10400,"price":60.2365,"value":626459.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":94784,"source":{"system":"sec-edgar","filing":"0001193125-26-401237","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708172/000119312526401237/ownership.xml","form_type":"4"}},{"id":4626359,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-09-24T21:35:13.000Z","date":"2026-09-22","kind":"exercise","planned":true,"acquired":true,"shares":10400,"price":13.62,"value":141648.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 476 shares acquired under the CRISPR Therapeutics AG 2026 Employee Stock Purchase Plan."}],"balance_after":105184,"source":{"system":"sec-edgar","filing":"0001193125-26-401237","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708172/000119312526401237/ownership.xml","form_type":"4"}},{"id":754778,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2026-06-02T21:42:26.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This restricted stock unit award was granted on May 29, 2026 with respect to 17,000 Common Shares, with 100% of the shares vesting on November 29, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This restricted stock unit award was granted on May 29, 2026 with respect to 17,000 Common Shares, with 100% of the shares vesting on November 29, 2028."}],"balance_after":17000,"derivative":{"underlying":"Common Shares","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001193125-26-253929","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526253929/ownership.xml","form_type":"4"}},{"id":829320,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T21:38:39.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":false,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."}],"balance_after":12000,"derivative":{"underlying":"Common Shares","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001193125-26-122274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122274/ownership.xml","form_type":"4"}},{"id":829319,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T21:38:39.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."}],"balance_after":25000,"derivative":{"underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-122274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122274/ownership.xml","form_type":"4"}},{"id":829318,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-24T21:38:39.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":38499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on March 20, 2026 with respect to 38,499 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2026."}],"balance_after":38499,"derivative":{"exercise_price":46.24,"expiration_date":"2036-03-20","underlying":"Common Shares","underlying_shares":38499},"source":{"system":"sec-edgar","filing":"0001193125-26-122274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122274/ownership.xml","form_type":"4"}},{"id":829317,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-03-24T21:38:39.000Z","date":"2026-03-23","kind":"sale","planned":false,"acquired":false,"shares":3182,"price":46.78,"value":148853.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":94308,"source":{"system":"sec-edgar","filing":"0001193125-26-122274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122274/ownership.xml","form_type":"4"}},{"id":829316,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-03-24T21:38:39.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":97490,"source":{"system":"sec-edgar","filing":"0001193125-26-122274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122274/ownership.xml","form_type":"4"}},{"id":837949,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:35:54.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":6875,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."}],"balance_after":20625,"derivative":{"underlying":"Common Shares","underlying_shares":6875},"source":{"system":"sec-edgar","filing":"0001193125-26-111281","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111281/ownership.xml","form_type":"4"}},{"id":837948,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-03-17T21:35:54.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":3450,"price":48.26,"value":166497.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":91240,"source":{"system":"sec-edgar","filing":"0001193125-26-111281","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111281/ownership.xml","form_type":"4"}},{"id":837947,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-03-17T21:35:54.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":6875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":94690,"source":{"system":"sec-edgar","filing":"0001193125-26-111281","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111281/ownership.xml","form_type":"4"}},{"id":846105,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2026-03-12T21:35:06.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."}],"balance_after":5500,"derivative":{"underlying":"Common Shares","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001193125-26-104481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526104481/ownership.xml","form_type":"4"}},{"id":846104,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-03-12T21:35:06.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":2800,"price":52.8,"value":147840.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":87815,"source":{"system":"sec-edgar","filing":"0001193125-26-104481","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526104481/ownership.xml","form_type":"4"}},{"id":846103,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-03-12T21:35:06.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":90615,"source":{"system":"sec-edgar","filing":"0001193125-26-104481","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526104481/ownership.xml","form_type":"4"}},{"id":890700,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2026-02-20T22:35:43.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":false,"shares":3825,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":3825},"source":{"system":"sec-edgar","filing":"0001193125-26-061710","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526061710/ownership.xml","form_type":"4"}},{"id":890699,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-02-20T22:35:43.000Z","date":"2026-02-19","kind":"sale","planned":false,"acquired":false,"shares":2112,"price":52.58,"value":111048.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":85115,"source":{"system":"sec-edgar","filing":"0001193125-26-061710","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526061710/ownership.xml","form_type":"4"}},{"id":890698,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2026-02-20T22:35:43.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":3825,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":87227,"source":{"system":"sec-edgar","filing":"0001193125-26-061710","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526061710/ownership.xml","form_type":"4"}},{"id":1018460,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2025-10-15T21:35:03.000Z","date":"2025-10-13","kind":"exercise","planned":false,"acquired":false,"shares":2114,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 6,340 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 6,340 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."}],"balance_after":2113,"derivative":{"underlying":"Common Shares","underlying_shares":2114},"source":{"system":"sec-edgar","filing":"0001193125-25-240437","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525240437/ownership.xml","form_type":"4"}},{"id":1018459,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2025-10-15T21:35:03.000Z","date":"2025-10-14","kind":"sale","planned":false,"acquired":false,"shares":1076,"price":66.6,"value":71661.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":83402,"source":{"system":"sec-edgar","filing":"0001193125-25-240437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525240437/ownership.xml","form_type":"4"}},{"id":1018458,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2025-10-15T21:35:03.000Z","date":"2025-10-13","kind":"exercise","planned":false,"acquired":true,"shares":2114,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 635 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan."}],"balance_after":84478,"source":{"system":"sec-edgar","filing":"0001193125-25-240437","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525240437/ownership.xml","form_type":"4"}},{"id":1024573,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-03T21:36:54.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 3, 2025 with respect to 16,500 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 3, 2025."}],"balance_after":16500,"derivative":{"exercise_price":67.74,"expiration_date":"2035-10-03","underlying":"Common Shares","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001193125-25-230506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525230506/ownership.xml","form_type":"4"}},{"id":1193472,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2025-03-24T21:35:04.000Z","date":"2025-03-20","kind":"exercise","planned":false,"acquired":false,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."}],"balance_after":18750,"derivative":{"underlying":"Common Shares","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000950170-25-043972","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025043972/ownership.xml","form_type":"4"}},{"id":1193471,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2025-03-24T21:35:04.000Z","date":"2025-03-21","kind":"sale","planned":false,"acquired":false,"shares":3185,"price":41.23,"value":131317.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":81729,"source":{"system":"sec-edgar","filing":"0000950170-25-043972","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025043972/ownership.xml","form_type":"4"}},{"id":1193470,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2025-03-24T21:35:04.000Z","date":"2025-03-20","kind":"exercise","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":84914,"source":{"system":"sec-edgar","filing":"0000950170-25-043972","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025043972/ownership.xml","form_type":"4"}},{"id":1199812,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2025-03-18T21:35:04.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."}],"balance_after":27500,"derivative":{"underlying":"Common Shares","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0000950170-25-041467","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025041467/ownership.xml","form_type":"4"}},{"id":1199811,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-18T21:35:04.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":36666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 14, 2025 with respect to 36,666 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 14, 2025."}],"balance_after":36666,"derivative":{"exercise_price":42.12,"expiration_date":"2035-03-14","underlying":"Common Shares","underlying_shares":36666},"source":{"system":"sec-edgar","filing":"0000950170-25-041467","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025041467/ownership.xml","form_type":"4"}},{"id":1209631,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2025-03-12T23:05:05.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":false,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0000950170-25-038215","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025038215/ownership.xml","form_type":"4"}},{"id":1209630,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2025-03-12T23:05:05.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."}],"balance_after":11000,"derivative":{"underlying":"Common Shares","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-25-038215","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025038215/ownership.xml","form_type":"4"}},{"id":1209629,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2025-03-12T23:05:05.000Z","date":"2025-03-12","kind":"sale","planned":false,"acquired":false,"shares":1116,"price":43.32,"value":48345.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":78664,"source":{"system":"sec-edgar","filing":"0000950170-25-038215","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025038215/ownership.xml","form_type":"4"}},{"id":1209628,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2025-03-12T23:05:05.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":true,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":79780,"source":{"system":"sec-edgar","filing":"0000950170-25-038215","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025038215/ownership.xml","form_type":"4"}},{"id":1209627,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2025-03-12T23:05:05.000Z","date":"2025-03-11","kind":"sale","planned":false,"acquired":false,"shares":2850,"price":42.42,"value":120897.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":77530,"source":{"system":"sec-edgar","filing":"0000950170-25-038215","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025038215/ownership.xml","form_type":"4"}},{"id":1209626,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2025-03-12T23:05:05.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":80380,"source":{"system":"sec-edgar","filing":"0000950170-25-038215","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025038215/ownership.xml","form_type":"4"}},{"id":1259987,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2025-02-19T22:35:03.000Z","date":"2025-02-18","kind":"exercise","planned":false,"acquired":false,"shares":3825,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."}],"balance_after":3825,"derivative":{"underlying":"Common Shares","underlying_shares":3825},"source":{"system":"sec-edgar","filing":"0000950170-25-023386","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025023386/ownership.xml","form_type":"4"}},{"id":1259986,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2025-02-19T22:35:03.000Z","date":"2025-02-16","kind":"exercise","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on August 16, 2022 with respect to 20,000 Common Shares, with 100% of the shares vesting on February 16, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on August 16, 2022 with respect to 20,000 Common Shares, with 100% of the shares vesting on February 16, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-25-023386","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025023386/ownership.xml","form_type":"4"}},{"id":1259985,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2025-02-19T22:35:03.000Z","date":"2025-02-19","kind":"sale","planned":false,"acquired":false,"shares":1947,"price":52.8,"value":102801.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":74880,"source":{"system":"sec-edgar","filing":"0000950170-25-023386","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025023386/ownership.xml","form_type":"4"}},{"id":1259984,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2025-02-19T22:35:03.000Z","date":"2025-02-18","kind":"exercise","planned":false,"acquired":true,"shares":3825,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":76827,"source":{"system":"sec-edgar","filing":"0000950170-25-023386","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025023386/ownership.xml","form_type":"4"}},{"id":1259983,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2025-02-19T22:35:03.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":9595,"price":53.85,"value":516690.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":73002,"source":{"system":"sec-edgar","filing":"0000950170-25-023386","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025023386/ownership.xml","form_type":"4"}},{"id":1259982,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2025-02-19T22:35:03.000Z","date":"2025-02-16","kind":"exercise","planned":false,"acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":82597,"source":{"system":"sec-edgar","filing":"0000950170-25-023386","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025023386/ownership.xml","form_type":"4"}},{"id":1384107,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2024-10-18T21:35:07.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on October 16, 2024 with respect to 30,000 Common Shares, with 100% of the shares vesting on October 16, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on October 16, 2024 with respect to 30,000 Common Shares, with 100% of the shares vesting on October 16, 2027."}],"balance_after":30000,"derivative":{"underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-24-115696","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024115696/ownership.xml","form_type":"4"}},{"id":1384106,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-18T21:35:07.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 16, 2024 with respect to 18,333 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 16, 2024."}],"balance_after":18333,"derivative":{"exercise_price":49,"expiration_date":"2034-10-16","underlying":"Common Shares","underlying_shares":18333},"source":{"system":"sec-edgar","filing":"0000950170-24-115696","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024115696/ownership.xml","form_type":"4"}},{"id":1386700,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2024-10-15T22:00:06.000Z","date":"2024-10-13","kind":"exercise","planned":false,"acquired":false,"shares":2113,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 6,340 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 6,340 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."}],"balance_after":4227,"derivative":{"underlying":"Common Shares","underlying_shares":2113},"source":{"system":"sec-edgar","filing":"0000950170-24-114787","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024114787/ownership.xml","form_type":"4"}},{"id":1386699,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2024-10-15T22:00:06.000Z","date":"2024-10-14","kind":"sale","planned":false,"acquired":false,"shares":1089,"price":46.28,"value":50398.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":62597,"source":{"system":"sec-edgar","filing":"0000950170-24-114787","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024114787/ownership.xml","form_type":"4"}},{"id":1386698,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2024-10-15T22:00:06.000Z","date":"2024-10-13","kind":"exercise","planned":false,"acquired":true,"shares":2113,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 399 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan."}],"balance_after":63686,"source":{"system":"sec-edgar","filing":"0000950170-24-114787","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024114787/ownership.xml","form_type":"4"}},{"id":1563389,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2024-03-22T21:45:06.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."}],"balance_after":25000,"derivative":{"underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-24-035517","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024035517/ownership.xml","form_type":"4"}},{"id":1563388,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-22T21:45:06.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 20, 2024 with respect to 33,333 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2024."}],"balance_after":33333,"derivative":{"exercise_price":72.94,"expiration_date":"2034-03-20","underlying":"Common Shares","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0000950170-24-035517","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024035517/ownership.xml","form_type":"4"}},{"id":1581113,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2024-03-12T21:45:09.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":false,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."}],"balance_after":2250,"derivative":{"underlying":"Common Shares","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0000950170-24-030190","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024030190/ownership.xml","form_type":"4"}},{"id":1581112,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2024-03-12T21:45:09.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":false,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."}],"balance_after":16500,"derivative":{"underlying":"Common Shares","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-24-030190","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024030190/ownership.xml","form_type":"4"}},{"id":1581111,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2024-03-12T21:45:09.000Z","date":"2024-03-12","kind":"sale","planned":false,"acquired":false,"shares":1146,"price":74.44,"value":85308.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":61174,"source":{"system":"sec-edgar","filing":"0000950170-24-030190","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024030190/ownership.xml","form_type":"4"}},{"id":1581110,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2024-03-12T21:45:09.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":true,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":62320,"source":{"system":"sec-edgar","filing":"0000950170-24-030190","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024030190/ownership.xml","form_type":"4"}},{"id":1581109,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2024-03-12T21:45:09.000Z","date":"2024-03-11","kind":"sale","planned":false,"acquired":false,"shares":2801,"price":78.26,"value":219206.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":60070,"source":{"system":"sec-edgar","filing":"0000950170-24-030190","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024030190/ownership.xml","form_type":"4"}},{"id":1581108,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2024-03-12T21:45:09.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":62871,"source":{"system":"sec-edgar","filing":"0000950170-24-030190","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024030190/ownership.xml","form_type":"4"}},{"id":1629313,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2024-02-21T22:45:22.000Z","date":"2024-02-18","kind":"exercise","planned":false,"acquired":false,"shares":3825,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."}],"balance_after":7650,"derivative":{"underlying":"Common Shares","underlying_shares":3825},"source":{"system":"sec-edgar","filing":"0000950170-24-018175","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024018175/ownership.xml","form_type":"4"}},{"id":1629312,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2024-02-21T22:45:22.000Z","date":"2024-02-20","kind":"sale","planned":false,"acquired":false,"shares":1913,"price":79.67,"value":152408.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":57371,"source":{"system":"sec-edgar","filing":"0000950170-24-018175","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024018175/ownership.xml","form_type":"4"}},{"id":1629311,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2024-02-21T22:45:22.000Z","date":"2024-02-18","kind":"exercise","planned":false,"acquired":true,"shares":3825,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 615 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan."}],"balance_after":59284,"source":{"system":"sec-edgar","filing":"0000950170-24-018175","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024018175/ownership.xml","form_type":"4"}},{"id":1759025,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2023-10-17T21:48:19.000Z","date":"2023-10-13","kind":"grant","planned":false,"acquired":true,"shares":6340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 6,340 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 6,340 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."}],"balance_after":6340,"derivative":{"underlying":"Common Shares","underlying_shares":6340},"source":{"system":"sec-edgar","filing":"0000950170-23-053817","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017023053817/ownership.xml","form_type":"4"}},{"id":1759024,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-17T21:48:19.000Z","date":"2023-10-13","kind":"grant","planned":false,"acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 13, 2023 with respect to 16,667 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 13, 2023."}],"balance_after":16667,"derivative":{"exercise_price":44.31,"expiration_date":"2033-10-13","underlying":"Common Shares","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0000950170-23-053817","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017023053817/ownership.xml","form_type":"4"}},{"id":1954227,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2023-03-14T21:45:39.000Z","date":"2023-03-11","kind":"exercise","acquired":false,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."}],"balance_after":4500,"derivative":{"underlying":"Common Shares","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001209191-23-018564","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123018564/doc4.xml","form_type":"4"}},{"id":1954226,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2023-03-14T21:45:39.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."}],"balance_after":22000,"derivative":{"underlying":"Common Shares","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-23-018564","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123018564/doc4.xml","form_type":"4"}},{"id":1954225,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-14T21:45:39.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on March 10, 2023 with respect to 40,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 10, 2023."}],"balance_after":40000,"derivative":{"exercise_price":43.22,"expiration_date":"2033-03-10","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-018564","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123018564/doc4.xml","form_type":"4"}},{"id":1954224,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2023-03-14T21:45:39.000Z","date":"2023-03-10","kind":"exercise","acquired":false,"shares":2833,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2020 with respect to 8,500 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2020 with respect to 8,500 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":2833},"source":{"system":"sec-edgar","filing":"0001209191-23-018564","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123018564/doc4.xml","form_type":"4"}},{"id":1954223,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2023-03-14T21:45:39.000Z","date":"2023-03-13","kind":"tax_withholding","acquired":false,"shares":1022,"price":43.22,"value":44170.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":54844,"source":{"system":"sec-edgar","filing":"0001209191-23-018564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123018564/doc4.xml","form_type":"4"}},{"id":1954222,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2023-03-14T21:45:39.000Z","date":"2023-03-11","kind":"exercise","acquired":true,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":55866,"source":{"system":"sec-edgar","filing":"0001209191-23-018564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123018564/doc4.xml","form_type":"4"}},{"id":1954221,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2023-03-14T21:45:39.000Z","date":"2023-03-13","kind":"tax_withholding","acquired":false,"shares":1283,"price":43.22,"value":55451.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":53616,"source":{"system":"sec-edgar","filing":"0001209191-23-018564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123018564/doc4.xml","form_type":"4"}},{"id":1954220,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2023-03-14T21:45:39.000Z","date":"2023-03-10","kind":"exercise","acquired":true,"shares":2833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":54899,"source":{"system":"sec-edgar","filing":"0001209191-23-018564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123018564/doc4.xml","form_type":"4"}},{"id":1999941,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2023-02-22T22:35:46.000Z","date":"2023-02-18","kind":"exercise","acquired":false,"shares":3825,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."}],"balance_after":11475,"derivative":{"underlying":"Common Shares","underlying_shares":3825},"source":{"system":"sec-edgar","filing":"0001209191-23-011777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123011777/doc4.xml","form_type":"4"}},{"id":1999940,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2023-02-22T22:35:46.000Z","date":"2023-02-21","kind":"tax_withholding","acquired":false,"shares":1950,"price":48.26,"value":94107.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":52066,"source":{"system":"sec-edgar","filing":"0001209191-23-011777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123011777/doc4.xml","form_type":"4"}},{"id":1999939,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2023-02-22T22:35:46.000Z","date":"2023-02-18","kind":"exercise","acquired":true,"shares":3825,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":54016,"source":{"system":"sec-edgar","filing":"0001209191-23-011777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123011777/doc4.xml","form_type":"4"}},{"id":2094521,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2022-12-06T22:47:09.000Z","date":"2022-12-03","kind":"exercise","acquired":false,"shares":6667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001209191-22-060090","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122060090/doc4.xml","form_type":"4"}},{"id":2094520,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2022-12-06T22:47:09.000Z","date":"2022-12-05","kind":"tax_withholding","acquired":false,"shares":3234,"price":52.26,"value":169008.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On December 3, 2019, the reporting person was granted 20,000 restricted stock units. On December 3, 2022, 6,667 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":50191,"source":{"system":"sec-edgar","filing":"0001209191-22-060090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122060090/doc4.xml","form_type":"4"}},{"id":2094519,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2022-12-06T22:47:09.000Z","date":"2022-12-03","kind":"exercise","acquired":true,"shares":6667,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 329 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan."}],"balance_after":53425,"source":{"system":"sec-edgar","filing":"0001209191-22-060090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122060090/doc4.xml","form_type":"4"}},{"id":2138321,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-12T21:40:15.000Z","date":"2022-10-07","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 7, 2022 with respect to 14,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 7, 2022."}],"balance_after":14000,"derivative":{"exercise_price":61.65,"expiration_date":"2032-10-07","underlying":"Common Shares","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-22-053494","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122053494/doc4.xml","form_type":"4"}},{"id":2179625,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2022-08-18T21:33:44.000Z","date":"2022-08-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full on February 16, 2025, subject to continued service to the Company or any of its subsidiaries."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full on February 16, 2025, subject to continued service to the Company or any of its subsidiaries."}],"balance_after":20000,"derivative":{"underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-046707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122046707/doc4.xml","form_type":"4"}},{"id":2335500,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2022-03-14T22:01:46.000Z","date":"2022-03-11","kind":"exercise","acquired":false,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."}],"balance_after":6750,"derivative":{"underlying":"Common Shares","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001209191-22-018609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122018609/doc4.xml","form_type":"4"}},{"id":2335499,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2022-03-14T22:01:46.000Z","date":"2022-03-10","kind":"exercise","acquired":false,"shares":2834,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 10, 2020 with respect to 8,500 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 10, 2020 with respect to 8,500 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023."}],"balance_after":2833,"derivative":{"underlying":"Common Shares","underlying_shares":2834},"source":{"system":"sec-edgar","filing":"0001209191-22-018609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122018609/doc4.xml","form_type":"4"}},{"id":2335498,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2022-03-14T22:01:46.000Z","date":"2022-03-14","kind":"tax_withholding","acquired":false,"shares":1039,"price":61.08,"value":63462.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":46429,"source":{"system":"sec-edgar","filing":"0001209191-22-018609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122018609/doc4.xml","form_type":"4"}},{"id":2335497,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2022-03-14T22:01:46.000Z","date":"2022-03-11","kind":"exercise","acquired":true,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":47468,"source":{"system":"sec-edgar","filing":"0001209191-22-018609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122018609/doc4.xml","form_type":"4"}},{"id":2335496,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2022-03-14T22:01:46.000Z","date":"2022-03-11","kind":"tax_withholding","acquired":false,"shares":1321,"price":62.56,"value":82641.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":45218,"source":{"system":"sec-edgar","filing":"0001209191-22-018609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122018609/doc4.xml","form_type":"4"}},{"id":2335495,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2022-03-14T22:01:46.000Z","date":"2022-03-10","kind":"exercise","acquired":true,"shares":2834,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 163 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan."}],"balance_after":46539,"source":{"system":"sec-edgar","filing":"0001209191-22-018609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122018609/doc4.xml","form_type":"4"}},{"id":2382387,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2022-02-22T22:40:40.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":15300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."}],"balance_after":15300,"derivative":{"underlying":"Common Shares","underlying_shares":15300},"source":{"system":"sec-edgar","filing":"0001209191-22-011836","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122011836/doc4.xml","form_type":"4"}},{"id":2382386,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-22T22:40:40.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":34200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 18, 2022 with respect to 34,200 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of March 18, 2022."}],"balance_after":34200,"derivative":{"exercise_price":58.29,"expiration_date":"2032-02-18","underlying":"Common Shares","underlying_shares":34200},"source":{"system":"sec-edgar","filing":"0001209191-22-011836","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919122011836/doc4.xml","form_type":"4"}},{"id":2482280,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2021-12-08T01:00:14.000Z","date":"2021-12-03","kind":"exercise","acquired":true,"shares":13333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022."}],"balance_after":6667,"derivative":{"underlying":"Common Shares","underlying_shares":13333},"source":{"system":"sec-edgar","filing":"0001209191-21-068453","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121068453/doc4.xml","form_type":"4"}},{"id":2482279,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2021-12-08T01:00:14.000Z","date":"2021-12-06","kind":"tax_withholding","acquired":false,"shares":6303,"price":69.17,"value":435978.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 3, 2019, the reporting person was granted 20,000 restricted stock units. On December 3, 2021, 13,333 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":43542,"source":{"system":"sec-edgar","filing":"0001209191-21-068453","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121068453/doc4.xml","form_type":"4"}},{"id":2482278,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2021-12-08T01:00:14.000Z","date":"2021-12-03","kind":"exercise","acquired":true,"shares":13333,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":49845,"source":{"system":"sec-edgar","filing":"0001209191-21-068453","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121068453/doc4.xml","form_type":"4"}},{"id":2485960,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-04T01:00:16.000Z","date":"2021-12-02","kind":"exercise","acquired":false,"shares":7342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 31, 2017 with respect to 123,000 Common Shares of which 25% vested on May 31, 2018 and the remaining 75% shall vest monthly thereafter for 36 months."}],"balance_after":93632,"derivative":{"exercise_price":13.62,"expiration_date":"2027-05-31","underlying":"Common Shares","underlying_shares":7342},"source":{"system":"sec-edgar","filing":"0001209191-21-068014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121068014/doc4.xml","form_type":"4"}},{"id":2485959,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2021-12-04T01:00:16.000Z","date":"2021-12-02","kind":"exercise","acquired":true,"shares":7342,"price":13.62,"value":99998.04,"ownership":{"direct":true},"balance_after":36512,"source":{"system":"sec-edgar","filing":"0001209191-21-068014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121068014/doc4.xml","form_type":"4"}},{"id":2540578,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-19T00:00:41.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":10800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 15, 2021 with respect to 10,800 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 15, 2021."}],"balance_after":10800,"derivative":{"exercise_price":97,"expiration_date":"2031-10-15","underlying":"Common Shares","underlying_shares":10800},"source":{"system":"sec-edgar","filing":"0001209191-21-060778","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121060778/doc4.xml","form_type":"4"}},{"id":2570792,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2021-09-15T01:45:31.000Z","date":"2021-09-10","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit award was granted on September 10, 2019 with respect to 10,000 Common Shares, with all shares vesting on September 10, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock unit award was granted on September 10, 2019 with respect to 10,000 Common Shares, with all shares vesting on September 10, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-056093","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121056093/doc4.xml","form_type":"4"}},{"id":2570791,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2021-09-15T01:45:31.000Z","date":"2021-09-13","kind":"tax_withholding","acquired":false,"shares":4741,"price":117.86,"value":558774.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":29170,"source":{"system":"sec-edgar","filing":"0001209191-21-056093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121056093/doc4.xml","form_type":"4"}},{"id":2570790,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2021-09-15T01:45:31.000Z","date":"2021-09-10","kind":"exercise","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock unit award was granted on September 10, 2019 with respect to 10,000 Common Shares, with all shares vesting on September 10, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":33911,"source":{"system":"sec-edgar","filing":"0001209191-21-056093","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121056093/doc4.xml","form_type":"4"}},{"id":2792096,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Restricted Stock Units","published_at":"2021-03-12T22:43:56.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."}],"balance_after":9000,"derivative":{"underlying":"Common Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-21-020253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121020253/doc4.xml","form_type":"4"}},{"id":2792095,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T22:43:56.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":25360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on March 11, 2021 with respect to 25,360 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 11, 2021."}],"balance_after":25360,"derivative":{"exercise_price":133.88,"expiration_date":"2031-03-11","underlying":"Common Shares","underlying_shares":25360},"source":{"system":"sec-edgar","filing":"0001209191-21-020253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121020253/doc4.xml","form_type":"4"}},{"id":2792094,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2021-03-12T22:43:56.000Z","date":"2021-03-10","kind":"tax_withholding","acquired":false,"shares":1353,"price":124.15,"value":167974.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":23911,"source":{"system":"sec-edgar","filing":"0001209191-21-020253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121020253/doc4.xml","form_type":"4"}},{"id":2792093,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2021-03-12T22:43:56.000Z","date":"2021-03-10","kind":"exercise","acquired":true,"shares":2833,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock unit award was granted on March 10, 2020 with respect to 8,500 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":25264,"source":{"system":"sec-edgar","filing":"0001209191-21-020253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121020253/doc4.xml","form_type":"4"}},{"id":2902397,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-20T23:05:14.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option was granted on March 7, 2018 with respect to 40,000 Common Shares and vests in 48 equal monthly installments."}],"balance_after":12500,"derivative":{"exercise_price":51.49,"expiration_date":"2028-03-07","underlying":"Common Shares","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001209191-21-004452","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004452/doc4.xml","form_type":"4"}},{"id":2902396,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2021-01-20T23:05:14.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":2100,"price":207.61,"value":435981.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.39 to $208.1050, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":22431,"source":{"system":"sec-edgar","filing":"0001209191-21-004452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004452/doc4.xml","form_type":"4"}},{"id":2902395,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":42394,"kind":"person","name":"KASINGER JAMES R.","position":1,"cik":"0001708172","reported_name":"KASINGER JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Shares","published_at":"2021-01-20T23:05:14.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":1800,"price":206.05,"value":370890.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.00 to $206.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":24531,"source":{"system":"sec-edgar","filing":"0001209191-21-004452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919121004452/doc4.xml","form_type":"4"}}],"next_cursor":"2021-01-20T23:05:14.000000Z,2902395"}